tiprankstipranks
Trending News
More News >
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
US Market

BioMarin Pharmaceutical (BMRN) Technical Analysis

Compare
2,362 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
BioMarin Pharmaceutical’s (BMRN) Moving Averages Convergence Divergence (MACD) indicator is -0.46, suggesting BioMarin Pharmaceutical is a Buy.
BioMarin Pharmaceutical’s (BMRN) 20-Day exponential moving average is 53.37, while BioMarin Pharmaceutical’s (BMRN) share price is $51.8, making it a Sell.
BioMarin Pharmaceutical’s (BMRN) 50-Day exponential moving average is 53.89, while BioMarin Pharmaceutical’s (BMRN) share price is $51.8, making it a Sell.

BioMarin Pharmaceutical (BMRN) Pivot Points

Dec 19, 2025, 12:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
50.32
50.89
51.33
51.91
52.35
52.92
53.36
Fibonacci
50.89
51.28
51.52
51.91
52.30
52.54
52.92
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioMarin Pharmaceutical (BMRN) Moving Averages

Dec 19, 2025, 12:30 AM
Period
Simple
Exponential
MA5
52.40Sell
52.33Sell
MA10
53.00Sell
52.88Sell
MA20
53.81Sell
53.37Sell
MA50
53.52Sell
53.89Sell
MA100
55.08Sell
55.07Sell
MA200
58.09Sell
58.13Sell
BioMarin Pharmaceutical’s (BMRN) 10-Day exponential moving average is 52.88, while BioMarin Pharmaceutical’s (BMRN) share price is $51.8, making it a Sell.
BioMarin Pharmaceutical’s (BMRN) 100-Day exponential moving average is 55.07, while BioMarin Pharmaceutical’s (BMRN) share price is $51.8, making it a Sell.
BioMarin Pharmaceutical’s (BMRN) stock price is $51.8 and BioMarin Pharmaceutical’s (BMRN) 50-day simple moving average is 53.52, creating a Sell signal.
BioMarin Pharmaceutical’s (BMRN) stock price is $51.8 and BioMarin Pharmaceutical’s (BMRN) 100-day simple moving average is 55.08, creating a Sell signal.
BioMarin Pharmaceutical’s (BMRN) stock price is $51.8 and BioMarin Pharmaceutical’s (BMRN) 200-day simple moving average is 58.09, creating a Sell signal.

BioMarin Pharmaceutical (BMRN) Technical Indicators

Dec 19, 2025, 12:30 AM
Name
Value
Implied Action
RSI (14)
39.03
Neutral
STOCH (9,6)
27.27
Neutral
STOCHRSI (14)
18.39
Buy
MACD (12,26)
-0.46
Buy
ADX (14)
16.40
Buy
Williams %R
-82.66
Buy
CCI (14)
-124.74
Buy
ATR (14)
1.37
-
Ultimate Oscillator
45.59
Neutral
ROC
-6.70
Sell
BioMarin Pharmaceutical’s (BMRN) Relative Strength Index (RSI) is 39.03, creating a Neutral signal.
BioMarin Pharmaceutical’s (BMRN) Trend Strength Indicator (ADX) is 16.40, creating a Buy signal.
BioMarin Pharmaceutical’s (BMRN) Commodity Channel Index (CCI) is -124.74, creating a Buy signal.
BioMarin Pharmaceutical’s (BMRN) Price Rate of Change (ROC) is -6.70, creating a Sell signal.

FAQ

Is BMRN a Buy, Hold, or Sell?
Based on BMRN’s technical indicators, BMRN is a Sell.
    What is BMRN’s RSI (14)?
    BMRN’s RSI (14) is 39.03, which suggests BMRN is a Neutral.
      What is BMRN’s MACD?
      BMRN’s MACD is -0.46, which suggests BMRN is a Buy.
        What is BMRN’s 5-day moving average?
        BMRN’s 5-day moving average is 52.40, which suggests BMRN is a Sell.
          What is BMRN’s 20-day moving average?
          BMRN 20-day moving average is 53.81, which suggests BMRN is a Sell.
            What is BMRN’s 50-day moving average?
            BMRN’s 50-day moving average is 53.52, which suggests BMRN is a Sell.
              What is BMRN’s 200-day moving average?
              BMRN’s 200-day moving average is 58.09, which suggests BMRN is a Sell.
                What is BMRN’s Williams % R (14)?
                BMRN’s Williams % R (14) is -82.66, which suggests BMRN is a Buy.
                  What is BMRN’s CCI (14)?
                  BMRN’s CCI (14) is -124.74, which suggests BMRN is a Buy.